Entera Bio Ltd (ENTX)

May 05, 2026

Entera Bio (ENTX) upgraded to buy: Here's what you should know - MSN

May 05, 2026

May 01, 2026

Entera Bio (ENTX) to Release Earnings on Friday - MarketBeat

May 01, 2026

Apr 29, 2026

Entera Bio (ENTX) Upgraded to Buy: Here's What You Should Know - sharewise.com

Apr 29, 2026

Apr 29, 2026

HC Wainwright Has Strong Estimate for Entera Bio Q1 Earnings - MarketBeat

Apr 29, 2026

Apr 28, 2026

What is HC Wainwright's Estimate for Entera Bio Q1 Earnings? - MarketBeat

Apr 28, 2026

Apr 27, 2026

HC Wainwright Has Lowered Expectations for Entera Bio (NASDAQ:ENTX) Stock Price - MarketBeat

Apr 27, 2026

Apr 27, 2026

H.C. Wainwright lowers Entera Bio stock price target on dilution By Investing.com - Investing.com South Africa

Apr 27, 2026

Apr 27, 2026

Entera Bio Price Target Cut to $9.00/Share From $10.00 by HC Wainwright & Co. - Moomoo

Apr 27, 2026

Apr 27, 2026

H.C. Wainwright lowers Entera Bio stock price target on dilution - Investing.com

Apr 27, 2026

Apr 24, 2026

Entera Bio Touts EB613 Oral Anabolic Tablet as Osteoporosis Care Gap Persists, Phase III Near - MarketBeat

Apr 24, 2026

Apr 24, 2026

Leading Osteoporosis Experts Are Lining Up Behind Entera Bio (NASDAQ: ENTX) - TradingView

Apr 24, 2026

Apr 23, 2026

Articles from Entera Bio Ltd. - FinancialContent

Apr 23, 2026

Apr 23, 2026

ENTX (Entera Bio Ltd. Ordinary Shares) rises 4.42 percent on Q4 2025 EPS beat despite sharp year over year revenue decline.Post Announcement - Xã Thanh Hà

Apr 23, 2026

Apr 23, 2026

ENTX (Entera Bio Ltd. Ordinary Shares) Q4 2025 narrower than expected loss pushes shares 6.67 percent higher in daily trading.Trending Volume Leaders - Xã Thanh Hà

Apr 23, 2026

Apr 22, 2026

ENTX (Entera Bio Ltd. Ordinary Shares) tops Q4 2025 EPS estimates, shares climb nearly seven percent on upbeat investor reaction.Real Trader Insights - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 20, 2026

ENTX: Oral anabolic EB613 could transform osteoporosis care by improving access and adherence - TradingView

Apr 20, 2026

Apr 20, 2026

ENTX: Oral anabolic EB613 could close major osteoporosis treatment gaps and improve patient outcomes - TradingView

Apr 20, 2026

Apr 20, 2026

BriefCast Publishes Transcript: Entera Bio's Osteoporosis KOL Roundtable on EB613Oral Anabolic Tablet Opportunity - Yahoo Finance

Apr 20, 2026

Apr 20, 2026

Entera Bio (ENTX) Stock: Institutional Signals (Technical Weakness) 2026-04-20Low Risk Entry - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 18, 2026

Entera Bio (ENTX) Stock: Worth Buying? (Investor Interest) 2026-04-18Fundamentals - Xã Châu Thành

Apr 18, 2026

Apr 16, 2026

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Apr 16, 2026

Apr 14, 2026

Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613 - marketscreener.com

Apr 14, 2026

Apr 14, 2026

Entera Bio to Host Key Opinion Leader Webinar Highlighting - GlobeNewswire

Apr 14, 2026

Apr 13, 2026

Should I Sell Entera Bio (ENTX) Stock Now | Price at $1.13, Down 1.74%Shared Trade Alerts - Newser

Apr 13, 2026

Apr 08, 2026

Bear Alert: Should I invest in Entera Bio Ltd before earnings2026 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn

Apr 08, 2026

Apr 06, 2026

Entera Bio raises $10M in private placement led by BVF Partners - Investing.com Australia

Apr 06, 2026

Apr 06, 2026

Greenberg Traurig Represents Entera Bio in $10M Private Placement - National Today

Apr 06, 2026

Apr 06, 2026

Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners - Bitget

Apr 06, 2026

Apr 06, 2026

Market Leaders: Is Entera Bio Ltd stock risky to hold now2026 Movers & AI Enhanced Execution Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 05, 2026

Entera Bio Ltd. Announces Private Placement and Securities Purchase Agreement for Phase 3 Osteoporosis Study Funding - Minichart

Apr 05, 2026

Apr 04, 2026

ENTX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Entera Bio Announces $10 Million Private Placement Financing - TipRanks

Apr 03, 2026

Apr 03, 2026

Entera Bio Raises $10 Million in Private Placement With BVF Partners, Adds Registration Rights - TradingView — Track All Markets

Apr 03, 2026

Apr 03, 2026

Entera Bio (NASDAQ: ENTX) completes private placement with BVF funds - Stock Titan

Apr 03, 2026

Apr 03, 2026

Entera Bio submits streamlined Phase 3 protocol for oral osteoporosis drug - Investing.com

Apr 03, 2026

Apr 02, 2026

Fresh $10M gives Entera Bio runway for Phase 3 osteoporosis study - Stock Titan

Apr 02, 2026

Apr 02, 2026

Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds - The Manila Times

Apr 02, 2026

Apr 01, 2026

Entera Bio Ltd. announced that it expects to receive $10 million in funding - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Denali Therapeutics Receives $200 Million Following FDA Accelerated Approval of Tividenofusp Alfa and Royalty Agreement Closing - Minichart

Apr 01, 2026

Mar 30, 2026

Net current asset value per share of Entera Bio Ltd. – LS:A2JQXP - TradingView

Mar 30, 2026

Mar 30, 2026

Stock market today: S&P 500, Dow futures gain as Trump calls Iran's new leaders 'very reasonable'—Palantir, Rezolve AI, Entera Bio in focus - MSN

Mar 30, 2026